Ecografía venosa en pacientes COVID-19 en Atención Primaria
- Fernández Rodríguez, Vicente 1
- Caeiro Castelao, Jesús Manuel 2
- Veras Castro, Ramón 3
- Pérez Coello, Lucía 3
- López Segade, Paula 1
- Anilo López, Carla 3
- Fernández Fernández, Bárbara 1
- Pallas Rodríguez, Macarena 2
- Bravo Bueno, Begoña 2
- 1 Centro de Saúde Os Rosales, A Coruña
- 2 Centro de Saúde Elviña-Mesoiro, A Coruña
- 3 Centro de Saúde San José, A Coruña
ISSN: 1134-3583
Año de publicación: 2023
Volumen: 29
Número: 1
Páginas: 40-47
Tipo: Artículo
Otras publicaciones en: Cadernos de atención primaria
Resumen
Objective: Estimate the proportion of patients with deep vein thrombosis in the lower extremities in patients with COVID-19 diagnosed and followed up in the community setting, as well as its association with different clinical variables and those considered vulnerability factors. Design: Cross-sectional study. Location: Primary Care (PC). Method/measurements: Ultrasound of the popliteal and femoral vein was performed on 216 patients from 3 basic health areas, selected consecutively from patients diagnosed with COVID-19. We consider pathological the absence of compressibility of the veins. Lung ultrasound is also performed and clinical variables, vulnerability factors and their relationship with radiographic results and hospital admission are recorded. Results: We did not find presence of femoral or popliteal venous thrombosis in any of the patients studied. The median number of days for the first examination is 4 (IQR 2-7). 9.3% were admitted to the hospital (95% CI 5.75-13.94). The proportion of cases with pathological lung ultrasound is 31.5% (95% CI 25.35-38.13) in the first ultrasound, 35.6% (95% CI 29.27-42.43) in first and subsequent. Conclusions: There is no increased risk of popliteal and femoral vein thrombosis due to mild-moderate COVID-19 in patients cared for at the community level. We think that the results of our study support the current recommendation of not performing prophylactic anticoagulation in general in patients with mild or moderate COVID-19, who are not eligible for hospital admission and who do not present clinical conditions with a previous higher thrombotic risk.